Peter Johnson

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study

A. Sheikh, K. Khunti, P. Horby, 2020, BMJ.

Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population

K. Khunti, P. Horby, J. Hippisley-Cox, 2020, medRxiv.

The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis

A. Hackshaw, D. Dwyer, Peter Johnson, 2020, The Lancet Oncology.

COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study

James J. Clark, Panneerselvam, T. Roques, 2022, European Journal of Cancer.

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study

K. Khunti, R. Keogh, J. Hippisley-Cox, 2021, BMJ.

Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study

M. Kivipelto, S. Hägg, M. Eriksdotter, 2022, Gerontology.

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

James J. Clark, T. Roques, T. Robinson, 2022, The Lancet Oncology.

Acute kidney injury and mortality risk in older adults with COVID-19

M. Kivipelto, M. Eriksdotter, A. Bruchfeld, 2021, Journal of Nephrology.

Coronial postmortem reports and indirect COVID-19 pandemic-related mortality

G. Rutty, M. Osborn, S. Suvarna, 2022, Journal of Clinical Pathology.

Development of an Electronic Frailty Index for Hospitalized Older Adults in Sweden

M. Kivipelto, S. Hägg, M. Eriksdotter, 2022, The journals of gerontology. Series A, Biological sciences and medical sciences.